Zentalis Pharmaceuticals
Clinical oncology innovator developing an investigational WEE1 inhibitor for ovarian cancer and multiple tumor types
123 employees · est. 2014 · San Diego, United States
Side-by-Side Comparison
| Metric | ACT Genomics | Zentalis Pharmaceuticals |
|---|---|---|
| Founded | ||
| Founded | 2014 | 2014 |
| Headquarters | ||
| Headquarters | Taiwan | San Diego, United States |
| Employees | ||
| Employees | 121 | 123 |
| Industry | ||
| Industry | Biotechnology, Health Care, Information Technology | Biopharma, Biotechnology, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Series Unknown | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $20.50M | $896.60M |
| Funding Rounds | ||
| Funding Rounds | 4 | 7 |
| Services | ||
| Services | Not tracked yet | Development of targeted cancer therapies, Clinical trial management, Pharmaceutical research and development, Patient-centered oncology solutions |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with Cyclin E1-Positive Platinum-Resistant Ovarian Cancer, Healthcare professionals specializing in oncology, Pharmaceutical investors, Clinical researchers |
| Taxonomy | ||
| Taxonomy | Personalized Medicine, Genomic Testing, Precision Medicine, Cancer Genomics, Bioinformatics, NGS Platform, Cancer Monitoring, Immunotherapy Evaluation, Clinical Services, Cancer Prevention, Early Detection, Treatment Selection, Disease Monitoring, Oncology, Molecular Information | Clinical Oncology, Ovarian Cancer Treatment, WEE1 Inhibitor, Monotherapy And Combination Studies, Non-Chemo Therapies, Orally Available Medicines, Small Molecule Medicine, Cancer Biological Pathways, New Chemical Entities, ER+/HER2- Breast Cancer, Advanced Solid Tumors, Biopharmaceutical Innovation, Therapeutics Development, Biomarker Expertise, Integrated Discovery Engine |
| Website | ||
| Website | actgenomics.com | zentalis.com |
About ACT Genomics
ACT Genomics is a world-leading genomic test solution provider founded in 2014 and headquartered in Taiwan. The company's slogan "Make Personalized Medicine Accessible To All" reflects its commitment to providing precision medicine services globally. ACT Genomics combines tumor biology, cancer genom...
About Zentalis Pharmaceuticals
Zentalis Pharmaceuticals is a clinical-stage biopharmaceutical company, founded in 2014, that specializes in innovative treatments for cancer, with a specific focus on ovarian cancer and various tumor types. Headquartered in the United States, Zentalis is at the forefront of oncology innovation. Th...
We will tell you when either one moves
BounceWatch watches ACT Genomics and Zentalis Pharmaceuticals for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at ACT Genomics and Zentalis Pharmaceutica... — by email.
Frequently Asked Questions
Compare ACT Genomics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at ACT Genomics on 12 Sep 2024, and Zentalis Pharmaceuticals on 10 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
